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Lymphokine (MIF) production by glomerular T-lymphocytes in exper-
imental glomerulonephritis. Glomerular T-Iymphocyte infiltration has
recently been demonstrated to precede glomerular macrophage influx in
a pre-immunized model of anti-glomerular basement—membrane
antibody—induced glomerulonephritis (antiGBM-GN) [1]. In the current
study, the functional role of these glomerular T-lymphocytes in direct-
ing macrophage localization was sought by measuring their production
of macrophage migration inhibition factor (MIF). MIF activity in
supernatants from cultured isolated glomeruli was measured in a
conventional capillary tube bioassay. Glomerular T-lymphocytes
(OX 19 positive cells) were maximal (1.95 0.19 cells/glomerular cross
section, c/gcs) 24 hours after injection of antiGBM antibody into
sensitized animals. Seventy—two hours after antibody injection, T-
lymphocyte numbers were reduced (1.02 0.14 c/gcs) while macro-
phage accumulation was maximal (at 24 hrs 4.2 1.3 macro-
phages/glomerulus (m/g), at 72 hrs 19.8 3.7 mlg). MIF activity was
only detected in supernatants from T-lymphocyte infiltrated glomeruli
(12 hrs 40.81 4.32% migration inhibition, 24 hrs 45.11 4.11%
migration inhibition, 48 hrs 38.24 3.53% migration inhibition, 72 hrs
20.86 3.85% migration inhibition, all P < 0.05). Control glomeruli
from normal animals, pre-immunized animals given normal sheep
globulin, pre-immunized animals given anti-GBM antibody and Cyclo-
sporin A, and non-pre-immunized animals given antiGBM antibody did
not contain glomerular T-lymphocytes, and their supernatants con-
tained no MIF activity. This data indicates that the glomerular T-
lymphocytes in pre-immunized antiGBM-GN are sensitized cells which
release MIF and thus may direct glomerular macrophage localization in
this model of antibody—induced glomerulonephritis.
Recent studies provide direct evidence for the involvement of
cell—mediated immunity (CMI) in the pathogenesis of experi-
mental glomerulonephritis (GN) [2—4]. Increased in vitro reac-
tivity of lymphocytes against selected antigens in some forms of
human GN [5—8], and the demonstration of a mononuclear cell
influx in a number of forms of human and experimental GN
[9—13] provides supportive, indirect evidence for the involve-
ment of CMI in nephritis. Although the pathogenetic role of
macrophages in glomerulonephritis has been clearly established
[14—16], the mechanisms directing glomerular macrophage lo-
calization have not been fully elucidated. Immune adherence
via the Fc portion of disease initiating immunoglobulin mole-
cules has been shown to be a potential mechanism for macro-
phage localization [17]. However, several forms of GN charac-
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terized by monocyte influx occur in the absence of immuno-
globulin deposition [18—20]. The role of the lymphokine
macrophage migration inhibition factor in directing glomerular
macrophage localization is unclear.
The kinetics of T-lymphocyte localization in the glomerulus
in an experimental model of preimmunized antiGBM GN have
recently been described [1]. In this model of GN, macrophage
accumulation and renal injury are preceded by infiltration of the
glomerulus by T-lymphocytes. The current study further char-
acterizes the kinetics of T-lymphocyte localization and reports
lymphokine production (MIF) by glomerular T-lymphocytes.
Lymphokine production by these sensitized T-lymphocytes
provides evidence for a functional role for the cell—mediated
immune system in directing macrophage accumulation, and
thereby the development of renal injury, in this model of
glomerulonephritis.
Methods
Experimental antiGBM GN
A pre-immunized and non-pre-immunized model of anti-
GBM GN were studied. Anti-rat GBM antibody was prepared
by repeated immunization of a sheep with purified particulate
rat GBM in Freund's complete adjuvant (FCA) as previously
described [21]. The sheep serum was extensively absorbed
against rat serum and red cells, and was administered as a
globulin fraction, as previously described [22].
To induce non-pre-immunized disease, a dose of 22 jg
globulin/g body wt, shown to bind 85 jg of kidney fixing
antibody (KFA)/g kidney (determined by binding studies using
1125 labelled antibody) [1] was administered intravenously (i.v.)
to male Sprague—Dawley rats, and glomerular injury assessed at
24 hours. Pre-immunized antiGBM GN was induced by pre-
immunization of rats with sheep globulin (4 mg in 0.75 ml FCA,
subcutaneously) followed five days later by 22 g globulin/g
body wt (85 g KFA/g kidney) of the same sheep anti-rat GBM
antibody.
Immunofluorescence microscopy
Tissue for immunofluorescence was frozen immediately in
liquid nitrogen, then stored at —70°C. Eight micron thick frozen
sections were cut on a cryostat and were stained with mono-
clonal mouse anti-rat T cell antibody 0X19 (ascites fluid). This
clone has been previously characterised as a pan-T cell marker
[23]. After initial titering experiments, the antibody was used at
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a dilution of 1:50 and the sections were subsequently stained
with fluorescinated goat anti-mouse IgG (Sigma Chemical, St.
Louis, Missouri, USA) absorbed with normal rat IgG. Controls
using the second antibody alone, normal mouse sera, and
phosphate buffered saline were performed. All T cell quantita-
tion experiments were conducted blind, the frozen tissue being
number coded. The results were obtained from three separate
experiments and represent overall means of the numbers of
cells in 10 glomeruli on three separate occasions. In separate
experiments, 100 glomeruli from known normal kidney tissue
were examined to determine the frequency of T cell accumula-
tion, as revealed with the monoclonal antibody.
Proteinuria. Rats were housed in metabolic cages to allow
collection of 24 hour urine samples. Protein concentrations
were determined by a turbidity assay [24]. Light transmission
(541 nm wavelength) was measured using a light spectropho-
tometer (Varian Techtron, Melbourne, Australia) 15 minutes
after the addition of three volumes 3% sulpho-salicylic acid to
one volume of urine samples. Values were calculated from a
standard curve derived from bovine serum albumin standards.
Histology. Kidney tissue samples were fixed in Bouin's
fixative and stained with periodic acid Schiff (PAS) reagent to
assess light microscopic appearances. Two techniques were
used to demonstrate macrophage accumulation within glomer-
uli. Frozen kidney tissue samples were cut into 8 micron
sections and stained for non-specific esterase by the method of
Yam, Li and Crosby [251. Staining was graded 0 to 4+,
according to the area of positive glomerular staining, to obtain
a semiquantitative estimate of the number of glomerular mac-
rophages, as described by Hunsicker et al [26], Fifty glomeruli
per rat kidney were examined.
Glomerular macrophages were also quantitated by glomeru-
lar cell culture [211. Glomeruli were isolated from aseptically
removed renal cortex and cultured individually in drops of
culture medium (Eagle's minimal essential medium (MEM),
Flow Laboratories, Melbourne, Australia) containing 10% fetal
calf serum (Flow Laboratories). After four days, macrophages
in the cellular outgrowths (previously identified by their light,
phase, cinematics, and electron microscopic appearances as
well as their histochemical profile, phagocytic behaviour, and
presence of Fc receptors [21]) were enumerated from at least 12
glomeruli per rat and expressed as the mean number of macro-
phages per glomerulus (mlg).
MIT assay of glomerular supernatants
Glomeruli were isolated by graded seiving techniques from
aseptically—obtained renal cortex as previously described [211.
Aliquots of glomeruli were cultured for 24 hours at 37°CI5%
CO2 in medium (Eagle's MEM). The glomeruli were then
removed by centrifugation at 1000 x g and the supernatants
retained. The ratio of supernatant to glomeruli was 1 ml to 4000
glomeruli. All samples were made to contain 15% guinea pig
serum and the pH adjusted to 7.5. Test and control samples
were assayed for migration inhibition activity on paraffin elic-
ited guinea pig peritoneal exudate cells, in capillary tubes, using
the method of David et al [27, 28]. All dilution of supernatant
samples was with media containing 15% guinea pig sera at p1-I
7.5. The "MIF positive" control solution used was prepared
from rat lymphocytes by the method of David [29], and pro-
duced between 38 and 56 percent migration inhibition in this
Glomerular
Protein Glomerular T-lymphocyte
excretion macrophage ceilsiglomerulur
Group description N rng/24hrs ciglom cross—section
7
12
7
8
90.1 16.5
107.2 23.1
184.7 27.3
242.6 39.7
3.7 1.2
4.2 1.3
11.2 2.9
19.8 3.7
1.68 0.18
1.95 0.19
1.45 0.17
1.02 0.14
6 108.3 14.6 0.6 0.2 0.03 0.03
16
5
9.4 1.2
74.4 18.1
0.1 0.01
0.08 0.04
0.00 0.00
0.00 0.00
10.5 1.3 0.02 0.01 0.00 0.00
assay. Migration was read after 18 hours by projection onto
bond paper. Migration inhibition was calculated by the formula.
average migration of
Migration inhibition 100 >< — cells in test samples(per cent) — average migration of
cells in media controls
Samples were assayed in quadruplicate.
Experimental design
Male Sprague—Dawley rats of approximately 250 g weight
were used for all experiments. The following groups were
studied:
(i) Preimmunized antiGBM GN. These animals were preim-
munized with sheep globulin in Freund's complete adjuvant,
injected with antiGBM antibody five days later, and were
sacrificed at 12 hours (N = 7), 24 hours (N = 12), 48 hours (N
= 7), and 72 hours (N = 8).
(ii) Controls. Four different controls groups were studied:
a. normal rats (N = 16);
b. rats with non-pre-immunized antiGBM GN (N = 6);
c. rats pre-imniunized with normal sheep globulin, injected
with non-immune sheep globulin five days later (in place of
antiGBM antibody) and then sacrificed after a further 24 hours
(N=5);
d. cyclosporin A treated, pre-immunized antiGBM GN rats.
Animals were processed as for pre-inimunized antiGBM UN
but given cyclosporin A (25 mg/kg/day) starting one day prior to
pre-immunization and continued until sacrifice at 24 hours (N =
5) (CYA treated).
Statistics
Results are expressed as mean SEM unless otherwise
stated. Comparisons between group data were made using
Student's t-test for unpaired data to determine significance.
Table 1. The development of glomerular injury and glomerular
T-lymphocyte counts
Pre-immunized
antiGBM UN
12 hrs
24 hrs
48 hrs
72 hrs
Controls
Non-pre-immunized
antiGBM UN
Normals
CyA treated
pre-immunized
antiUBM UN
Pre-immunized rats 5
given non-
immune globulin
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Fig. 1. Immunofluorescence micrograph of glomerular T-lymphocytes, as demonstrated with the 0X19 monoclonal marker.
Results
The development of glomerular injury (Table 1)
Pre-immunized antiGBM GN. At 12 and 24 hours animals had
a minor macrophage ingress (3.7 1.2 and 4.2 1.3 m/g) with
significant proteinuria (90.1 16.5 and 107 23.1 mg/24 hrs).
At 48 hours and 72 hours, the macrophage influx has increased
(11.2 2.9 and 19.8 3.7 m/g) as had the degree of proteinuria
(184.7 27.3 and 242.6 39.7 mg/24 hours). The results of
esterase staining of macrophages within glomeruli correlated
with the estimation of macrophages in glomerular culture.
Staining was slight at 12 and 24 hrs (+ 1), increased (+3) at 48
hrs and maximal at 72 hrs (+4).
Controls. Normal animals had no abnormal protein excretion
(9.4 1.2 mg!24 hrs) and no glomerular macrophage accumu-
lation (0.1 0.01 mlg). The non-pre-immunized antiGBM ON
had significant proteinuria (108.3 14.6 mg/24 hrs) and a diffuse
proliferative glomerulonephritis with a predominant polymor-
phonuclear leucocyte infiltrate, as previously described [221.
CyA treated animals had significant proteinuria (74.4 18.1
mg/24 hrs) without glomerular macrophage ingress (0.08 0.04
m!g). Pre-immunized rats given non-immune sheep globulin
also had no abnormal proteinuria (10.5 1.3 mg124 hrs) and no
glomerular macrophage accumulation (0.02 0.01 m/g). In all
control groups there were only occasional areas of ester-
ase—positive glomerular staining (0 to + 1).
Glomerular T-lymphocyte counts (Table 1)
Pre-immunized antiGBM GN. T-lymphocyte counts were
1.68 0.18 c/gsc at 12 hours, were maximal (1.95 0.19 c/gcs)
at 24 hours. There was a reduction in T-lymphocyte infiltration
at 48 and 72 hours of disease (1.45 0.17 and 1.02 0.14 c/gcs)
(Fig. I).
Controls. Glomeruli from all the control groups of animals
had no significant T-lymphocyte infiltration (normal 0.00 0.00
c/gcs; non-pre-immunized antiGBM GN 0.03 0.03 c/gcs; CyA
treated pre-immunized antiGBM GN 0.00 0.00 c/gcs; pre-
immunized rats given non-immune globulin 0.00 0.00 c/gcs).
MIF production (Table 2)
Pre-immunized antiGBM GN. Supernatants from glomeruli
of animals sacrificed at 24 hours gave maximal MIF activity
(migration inhibition 45.11 4.13%), and this activity was
titratable to a dilution of 1:3 (Fig. 2). Glomerular supernatants
from animals sacrificed at 12, 48 and 72 hours also demon-
strated MIF activity (migration inhibition 40.81 4.32%, 38.24
3.53% and 20.86 3.85%). MIF activity was demonstrable in
dilution of supernatants of glomeruli of animals sacrificed at 12
and 48 hours, although no significant migration inhibition oc-
curred in dilution of supernatants from animals sacrificed at 72
hours (15.38 8.33% at 3:1 dilution, 10.38 3.36% at 1:1
dilution and 2.05 4.07% at 1:3 dilution). Migration inhibition
(that is, MIF activity) was significantly greater (P < 0.05, Table
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Dilution of
Group description N supernatant MIF
Pre-immunized
antiGBM GN
12 hrs 7 — 40.81 4.32
3:1 30.42 4.13
1:1 23.58 2.80
1:3 16.21 2.99
— 45.11 4.13
3:1 37.05 3.38
1:1 26.48 3.32
1:3 18.35 2.39
— 38.24 3.53 <0.01
3:1 24.79±4.22 <0.01
1:1 18.98 2.70 <0.05
1:3 11.81 4.15 N,S.
— 20.86 3.85 <0.05
3:1 15.38 8.33 N.S.
1:1 10.38 3.36 N.S.
1:3 2.05±4.07 N.S.
The demonstration of a glomerular T-lymphocyte infiltrate,
N.S. preceding macrophage ingress, in a pre-immunized model of
antiGBM GN [1] suggested the participation of CMI in the
evolution of glomerular injury. The local (that is, glomerular)
production of the lymphokine 'macrophage migration inhibition
factor' (MIF) provided a means with which to assess the
MS. potential for glomerular T-lymphocytes to contribute to glomer-
ular macrophagc localization. Sensitized T-lymphocytes se-
crete a variety of lymphokines, including several moieties
potentially able to effect macrophage migration [30]. In the
N.S. current study, the standard bioassay for MIF was adapted to
measure lymphokine activity in the supernatants of isolated
glomeruli in short—term culture. Supernatants from glomeruli
devoid of T-lymphocytes did not effect macrophage migration,
however, supernatants from T-lymphocyte containing glomer-
uli significantly inhibited macrophage migration (were MIF
positive). The absolute magnitude of migration inhibition and
the persistence of MIF activity in serial dilution correlated with
the number of T-lymphocytes within glomeruli (maximal at 24
hrs with 1.95 0.19 T-lymphocytes/gcs: least at 72 hrs with
1.02 0.14 T-lymphocytes/gcs). Macrophage migration inhibi-
tion was not due to the production of non-specific inhibitory
substance by damaged glomeruli or neutrophils, as there was no
MIF activity in supernatants from the T-lymphocyte free,
neutrophil—infiltrated nephritic glomeruli of non-pre-immunized
antiGBM GN. Further, the reduced MIF activity at 72 hours in
the model of pre-immunized antiGBM GN, despite greater
injury (more macrophage influx and heavier proteinuria), reaf-
firms that non-lymphokinc products of glomerular inflammation
do not inhibit macrophage migration.
We chose the monoclonal T-lymphocyte marker 0X19 for
this study in preference to previously used markers (W3/13,
W3!25 and 0X8) because of its greater T-cell specificity [23].
Using 0X19 and more frequent tissue sampling, the timing and
Table 2. MIF activity of glomerular supernatants
pa
Zr
.0
.0
C
<0.01
<0.01
<0.05
N.S.
a)
C)
<0.01 .2
<0.01
<0.01
<0.05
24 hrs 12
48hrs 7
72hrs 8
Controls
Non-pre-immunized 6
antiGBM GM
Normals 16
CyA treated 5
pre-immunized
antiGBM GM
Pre-immunized rats 5
given
non-immune
globulin
3:1 1:1 1:3
Diluta of glomerular supernatant
N.S.
MS.
N.S.
MS.
Fig. 2. The glomerular supernatants from animals with maximal T-
lymphocyte infiltration demonstrated MIF activity in dilutions up to
1:3. Shaded area is mean 2 so for normal glomerular supernatant.
Discussion
— 6.12 1.50
3:1 6.62 3.11
1:1 —0.51 3.52
1:3 —1.18 2.51
— )3.28 1.36
3:!
1:1
1:3
— )0.94 1.13
1:1
3:1
1:3
— )1.25 0.97
3:1
1:1
1:3
a P is significance value for comparing migration in test sample and in
media control.
2) in the glomerutar supernatants from animals sacrificed at 12,
24, 48 and 72 hours of disease, regardless of whether compar-
ison was made with macrophage migration in media alone or
with migration in the glomerular supernatants of animals in any
of the control groups.
Controls. Supernatants from normal glomeruli gave 3.28
1.36% inhibition. Glomerular supernatants from non-pre-im-
munized antiGBM GN gave 6.12 1.50% inhibition. Superna-
tants from CyA treated, pre-immunized antiGBM GN gave 0.94
1.13% inhibition. Supernatants from pre-immunized rats
given non-immune globulin gave 1.25 0.97% inhibition. The
degree of inhibition of macrophage migration in these control
groups was not significantly different from migration in media
alone.
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extent of glomerular T-lymphocyte infiltration was similar to
that described in the previous study [1]. The current study thus
confirms and expands the reported kinetics and magnitude of
glomerular T-lymphocyte ingress in the pre-immunized model
of antiGBM GN.
The potential for CMI to produce glomerular macrophage
accumulation was demonstrated by the cell—transfer studies of
Bhan et al [2, 31, and by the avian model of GN of Boltin,
Tucker and Sturgill [4], although in these studies lymphocytes
were not demonstrated in glomeruli. The current study demon-
strates the production of a lymphokine (MIF) by sensitized
T-lymphocytes localized within glomeruli. This functional
expression of cell mediated immunity occurred early in the
course of an experimental model of GN which was character-
ized by extensive histological and functional abnormalities.
These findings demonstrate a potential role for lymphokine
production by glomerular T-lymphocytes in directing glomeru-
lar macrophage accumulation in this model of GN. CMI may
conceivably contribute to inflammatory cell localization in
other forms of human and experimental GN via similar T
cell-macrophage interactions.
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